Telmisartan Research Compound Overview
Telmaheal 40 mg is a pharmaceutical-grade angiotensin II receptor blocker manufactured by Healing Pharma, specifically formulated for laboratory research applications. This compound represents one of the most extensively studied angiotensin receptor antagonists, offering researchers access to a well-characterized molecular tool for investigating cardiovascular and metabolic pathways in controlled laboratory environments.
Research teams investigating renin-angiotensin-aldosterone system (RAAS) modulation will find this compound particularly valuable for examining receptor binding kinetics and downstream signalling cascades. The standardised 40 mg formulation ensures consistent experimental conditions across multiple research protocols, supporting reproducible analytical outcomes in academic and commercial laboratory settings.
Laboratory Research Applications
Telmisartan serves as an essential research tool for scientists examining angiotensin II type 1 (AT1) receptor antagonism in various experimental models. Researchers at leading institutions utilise this compound to investigate blood pressure regulation mechanisms, aldosterone synthesis pathways, and cardiovascular remodelling processes in controlled laboratory conditions.
The compound’s unique pharmacological profile makes it particularly suitable for comparative studies against other RAAS modulators available through Stroid UK Shop. Research applications span from basic receptor binding assays to complex multi-pathway interaction studies, with particular relevance in metabolic research where investigators examine insulin sensitivity and glucose homeostasis pathways.
Advanced research protocols often incorporate telmisartan alongside compounds from our comprehensive telmisartan research collection to examine synergistic effects and pathway cross-talk mechanisms. Many research teams also investigate potential interactions with selective androgen receptor modulators and research peptides when studying complex metabolic interactions.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Telmisartan |
| Manufacturer | Healing Pharma |
| Strength | 40 mg per unit |
| Product Code | EU11070 |
| Storage Requirements | Room temperature, dry conditions |
| Research Classification | Angiotensin II receptor antagonist |
Research Compliance Information
Telmaheal 40 mg by Healing Pharma is manufactured exclusively for in-vitro laboratory research purposes and analytical studies. This product is not intended for human consumption, therapeutic use, or any applications outside controlled laboratory environments. Researchers must ensure appropriate safety protocols and waste disposal procedures are implemented when handling this research compound. All studies should be conducted in accordance with institutional research guidelines and applicable laboratory safety standards.
